世界の前立腺特異抗原（PSA）血液ベースバイオマーカー市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4773 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、前立腺特異抗原（PSA）血液ベースバイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（スクリーニングバイオマーカー、診断バイオマーカー）、用途別市場規模（診断、創薬、個別化医療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・前立腺特異抗原（PSA）血液ベースバイオマーカーの市場動向 ・企業の競争状況、市場シェア ・前立腺特異抗原（PSA）血液ベースバイオマーカーの種類別市場規模と予測2016-2027（スクリーニングバイオマーカー、診断バイオマーカー） ・前立腺特異抗原（PSA）血液ベースバイオマーカーの用途別市場規模と予測2016-2027（診断、創薬、個別化医療、その他） ・前立腺特異抗原（PSA）血液ベースバイオマーカーの北米市場規模2016-2027（アメリカ、カナダ） ・前立腺特異抗原（PSA）血液ベースバイオマーカーの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・前立腺特異抗原（PSA）血液ベースバイオマーカーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・前立腺特異抗原（PSA）血液ベースバイオマーカーの中南米市場規模2016-2027（メキシコ、ブラジル） ・前立腺特異抗原（PSA）血液ベースバイオマーカーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（ProteoMediX、Cleveland Diagnostics、Randox、Roche、GENFIT、Nutech Cancer Biomarkers、OGT (Sysmex Group)、Minomic、Creative Diagnostics） ・結論

Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis.

Market Analysis and Insights: Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market
The global Prostate Specific Antigen (PSA) Blood Based Biomarker market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostate Specific Antigen (PSA) Blood Based Biomarker market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostate Specific Antigen (PSA) Blood Based Biomarker market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostate Specific Antigen (PSA) Blood Based Biomarker market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostate Specific Antigen (PSA) Blood Based Biomarker market.

Global Prostate Specific Antigen (PSA) Blood Based Biomarker Scope and Market Size
Prostate Specific Antigen (PSA) Blood Based Biomarker market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Specific Antigen (PSA) Blood Based Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Screening Biomarker
Diagnosis Biomarker

Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
ProteoMediX
Cleveland Diagnostics
Randox
Roche
GENFIT
Nutech Cancer Biomarkers
OGT (Sysmex Group)
Minomic
Creative Diagnostics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Screening Biomarker
1.2.3 Diagnosis Biomarker
1.3 Market by Application
1.3.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Perspective (2016-2027)
2.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Growth Trends by Regions
2.2.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Historic Market Share by Regions (2016-2021)
2.2.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Regions (2022-2027)
2.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Industry Dynamic
2.3.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Trends
2.3.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Drivers
2.3.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Challenges
2.3.4 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Prostate Specific Antigen (PSA) Blood Based Biomarker Players by Revenue
3.1.1 Global Top Prostate Specific Antigen (PSA) Blood Based Biomarker Players by Revenue (2016-2021)
3.1.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Players (2016-2021)
3.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue
3.4 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Concentration Ratio
3.4.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue in 2020
3.5 Prostate Specific Antigen (PSA) Blood Based Biomarker Key Players Head office and Area Served
3.6 Key Players Prostate Specific Antigen (PSA) Blood Based Biomarker Product Solution and Service
3.7 Date of Enter into Prostate Specific Antigen (PSA) Blood Based Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Specific Antigen (PSA) Blood Based Biomarker Breakdown Data by Type
4.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Historic Market Size by Type (2016-2021)
4.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Type (2022-2027)

5 Prostate Specific Antigen (PSA) Blood Based Biomarker Breakdown Data by Application
5.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Historic Market Size by Application (2016-2021)
5.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2016-2027)
6.2 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
6.2.1 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021)
6.2.2 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027)
6.2.3 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2027)
6.3 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application
6.3.1 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021)
6.3.2 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027)
6.3.3 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2027)
6.4 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country
6.4.1 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2016-2021)
6.4.2 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2016-2027)
7.2 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
7.2.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021)
7.2.2 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027)
7.2.3 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2027)
7.3 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application
7.3.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021)
7.3.2 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027)
7.3.3 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2027)
7.4 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country
7.4.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2016-2021)
7.4.2 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2016-2027)
8.2 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
8.2.1 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2027)
8.3 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application
8.3.1 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2027)
8.4 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region
8.4.1 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2016-2027)
9.2 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
9.2.1 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021)
9.2.2 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027)
9.2.3 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2027)
9.3 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application
9.3.1 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021)
9.3.2 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027)
9.3.3 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2027)
9.4 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country
9.4.1 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2016-2021)
9.4.2 Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2016-2027)
10.2 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type
10.2.1 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2027)
10.3 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application
10.3.1 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2027)
10.4 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country
10.4.1 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 ProteoMediX
11.1.1 ProteoMediX Company Details
11.1.2 ProteoMediX Business Overview
11.1.3 ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
11.1.4 ProteoMediX Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
11.1.5 ProteoMediX Recent Development
11.2 Cleveland Diagnostics
11.2.1 Cleveland Diagnostics Company Details
11.2.2 Cleveland Diagnostics Business Overview
11.2.3 Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
11.2.4 Cleveland Diagnostics Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
11.2.5 Cleveland Diagnostics Recent Development
11.3 Randox
11.3.1 Randox Company Details
11.3.2 Randox Business Overview
11.3.3 Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
11.3.4 Randox Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
11.3.5 Randox Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
11.4.4 Roche Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
11.4.5 Roche Recent Development
11.5 GENFIT
11.5.1 GENFIT Company Details
11.5.2 GENFIT Business Overview
11.5.3 GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
11.5.4 GENFIT Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
11.5.5 GENFIT Recent Development
11.6 Nutech Cancer Biomarkers
11.6.1 Nutech Cancer Biomarkers Company Details
11.6.2 Nutech Cancer Biomarkers Business Overview
11.6.3 Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
11.6.4 Nutech Cancer Biomarkers Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
11.6.5 Nutech Cancer Biomarkers Recent Development
11.7 OGT (Sysmex Group)
11.7.1 OGT (Sysmex Group) Company Details
11.7.2 OGT (Sysmex Group) Business Overview
11.7.3 OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
11.7.4 OGT (Sysmex Group) Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
11.7.5 OGT (Sysmex Group) Recent Development
11.8 Minomic
11.8.1 Minomic Company Details
11.8.2 Minomic Business Overview
11.8.3 Minomic Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
11.8.4 Minomic Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
11.8.5 Minomic Recent Development
11.9 Creative Diagnostics
11.9.1 Creative Diagnostics Company Details
11.9.2 Creative Diagnostics Business Overview
11.9.3 Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction
11.9.4 Creative Diagnostics Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
11.9.5 Creative Diagnostics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Screening Biomarker
Table 3. Key Players of Diagnosis Biomarker
Table 4. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Regions (2016-2021)
Table 8. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Regions (2022-2027)
Table 10. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Trends
Table 11. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Drivers
Table 12. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Challenges
Table 13. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Restraints
Table 14. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Players (2016-2021)
Table 16. Global Top Prostate Specific Antigen (PSA) Blood Based Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker as of 2020)
Table 17. Ranking of Global Top Prostate Specific Antigen (PSA) Blood Based Biomarker Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Prostate Specific Antigen (PSA) Blood Based Biomarker Product Solution and Service
Table 21. Date of Enter into Prostate Specific Antigen (PSA) Blood Based Biomarker Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Type (2016-2021)
Table 25. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Application (2016-2021)
Table 29. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 61. ProteoMediX Company Details
Table 62. ProteoMediX Business Overview
Table 63. ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Product
Table 64. ProteoMediX Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
Table 65. ProteoMediX Recent Development
Table 66. Cleveland Diagnostics Company Details
Table 67. Cleveland Diagnostics Business Overview
Table 68. Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product
Table 69. Cleveland Diagnostics Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
Table 70. Cleveland Diagnostics Recent Development
Table 71. Randox Company Details
Table 72. Randox Business Overview
Table 73. Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Product
Table 74. Randox Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
Table 75. Randox Recent Development
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Product
Table 79. Roche Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
Table 80. Roche Recent Development
Table 81. GENFIT Company Details
Table 82. GENFIT Business Overview
Table 83. GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Product
Table 84. GENFIT Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
Table 85. GENFIT Recent Development
Table 86. Nutech Cancer Biomarkers Company Details
Table 87. Nutech Cancer Biomarkers Business Overview
Table 88. Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Product
Table 89. Nutech Cancer Biomarkers Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
Table 90. Nutech Cancer Biomarkers Recent Development
Table 91. OGT (Sysmex Group) Company Details
Table 92. OGT (Sysmex Group) Business Overview
Table 93. OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Product
Table 94. OGT (Sysmex Group) Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
Table 95. OGT (Sysmex Group) Recent Development
Table 96. Minomic Company Details
Table 97. Minomic Business Overview
Table 98. Minomic Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
Table 99. Minomic Recent Development
Table 100. Creative Diagnostics Company Details
Table 101. Creative Diagnostics Business Overview
Table 102. Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product
Table 103. Creative Diagnostics Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021) & (US$ Million)
Table 104. Creative Diagnostics Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type: 2020 VS 2027
Figure 2. Screening Biomarker Features
Figure 3. Diagnosis Biomarker Features
Figure 4. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application: 2020 VS 2027
Figure 5. Diagnostics Case Studies
Figure 6. Drug Discovery Case Studies
Figure 7. Personalized Medicine Case Studies
Figure 8. Others Case Studies
Figure 9. Prostate Specific Antigen (PSA) Blood Based Biomarker Report Years Considered
Figure 10. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Regions: 2020 VS 2027
Figure 13. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Regions (2022-2027)
Figure 14. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Players in 2020
Figure 15. Global Top Prostate Specific Antigen (PSA) Blood Based Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue in 2020
Figure 17. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Type (2016-2021)
Figure 18. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Type (2022-2027)
Figure 19. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2016-2027)
Figure 21. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2016-2027)
Figure 22. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Country (2016-2027)
Figure 23. United States Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2016-2027)
Figure 27. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2016-2027)
Figure 28. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Country (2016-2027)
Figure 29. Germany Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Region (2016-2027)
Figure 39. China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2016-2027)
Figure 47. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2016-2027)
Figure 48. Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Country (2016-2027)
Figure 49. Mexico Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Country (2016-2027)
Figure 55. Turkey Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. ProteoMediX Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
Figure 59. Cleveland Diagnostics Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
Figure 60. Randox Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
Figure 62. GENFIT Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
Figure 63. Nutech Cancer Biomarkers Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
Figure 64. OGT (Sysmex Group) Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
Figure 65. Minomic Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
Figure 66. Creative Diagnostics Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---